3 Healthcare Stocks See New Analyst Price Targets Week Ending Nov. 18th

Wall St. Watchdog reveals information about companies for which stock analysts reiterated ratings in the Healthcare sector for the week ending November 18th, 2011.

  • Vertex Pharm (NASDAQ:VRTX): Canaccord Genuity reiterated its rating of Hold for this company and changed its price target from $43 to $33 on Nov 14th. The shares recently traded at $27.56, down $2.47, or 8.23% since the analyst’s rating. About the company: Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases. Get the most recent company news and stock data here >>
  • Cadence Pharma (NASDAQ:CADX): UBS reiterated its rating of Neutral for this company and changed its price target from $7 to $4 on Nov 17th. The shares recently traded at $4.47, up $0.49, or 12.31% since the analyst’s rating. About the company: Cadence Pharmaceuticals Inc. is a biopharmaceutical company that develops drugs for use in hospitals. The Company produces intravenous APAP for the treatment of acute pain and fever, and omiganan for the prevention of intravascular catheter-related infections. Get the most recent company news and stock data here >>
  • SonoSite (NASDAQ:SONO): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $43 to $47 on Nov 18th. The shares recently traded at $40.60, down $0.78, or 1.88% since the analyst’s rating. About the company: SonoSite, Inc. manufactures hand-held ultrasound imaging equipment. The Company’s equipment is approximately the size of a laptop computer and permits the provision of ultrasound services in places previously not possible. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>